Wilhelmus Cm Groenhuysen, Chief Financial Officer at NovoCure Ltd (NVCR), sold 37,816 shares at $81.16 ($3.1M) on 2020-02-25, disclosed to the SEC on 2020-02-26.
Open-market sale of $3.1M NVCR by Chief Financial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $81.16 | 18,908 | $1.5M | 50.0% |
| 2 | $81.16 | 18,908 | $1.5M | 50.0% |
| Total | $81.16 avg | 37,816 | $3.1M | 100% |
| Filing → |
| NVCR | SELL | 2023-09-05 | $6K | — | Filing → |
| NVCR | SELL | 2023-03-07 | $3.9M | — | Filing → |
| NVCR | SELL | 2023-03-06 | $183K | — | Filing → |